Compound ID | 2203
Synonym(s): LCB18-055
Class: Beta-lactamase inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active in combination with GT-1 against Acinetobacter baumannii, Citrobacter species, Enterobacter sp., Escherichia coli, Klebsiella pneumoniae, Klebsiella sp., Kluyvera ascorbate, Morganella morganii, Proteus mirabilis, Providencia spp., Pseudomonas aeruginosa, Raoultella ornithinolytica, Salmonella spp., Serratia marcescens, Shigella sonnei |
| Description: | Synthetic compound; shows synergistic antimicrobial effect with GT-1 (LCB10-200) against Escherichia coli, Klebsiella pneumoniae and Acinetobacter spp. |
| Year first mentioned: | 2020 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/163323732 |
| Citations: |
|